| | Per Share | | | Total | |
Public offering price | | | $11.00 | | | $40,000,004.00 |
Underwriting discount and commissions(a) | | | $0.77 | | | $2,800,000.28 |
Proceeds, before expenses, to Gain Therapeutics, Inc. | | | $10.23 | | | $37,200,003.70 |
(a) | See “Underwriting” for a complete description on the compensation payable to the underwriters. |
BTIG | | | Oppenheimer & Co. |
| | ||
National Securities Corporation |